These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33828990)
1. A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma. Cheng M; Sun L; Huang K; Yue X; Chen J; Zhang Z; Zhao B; Bian E Front Oncol; 2021; 11():646409. PubMed ID: 33828990 [TBL] [Abstract][Full Text] [Related]
2. An autophagy-related long non-coding RNA signature for glioma. Luan F; Chen W; Chen M; Yan J; Chen H; Yu H; Liu T; Mo L FEBS Open Bio; 2019 Apr; 9(4):653-667. PubMed ID: 30984540 [TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma. Huang K; Yue X; Zheng Y; Zhang Z; Cheng M; Li L; Chen Z; Yang Z; Bian E; Zhao B Front Oncol; 2021; 11():726745. PubMed ID: 34540695 [TBL] [Abstract][Full Text] [Related]
4. A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma. Zheng Y; Yue X; Fang C; Jia Z; Chen Y; Xie H; Zhao J; Yang Z; Li L; Chen Z; Bian E; Zhao B Front Oncol; 2022; 12():930923. PubMed ID: 35847925 [TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of a novel 5 methylated snoRNA genes prognostic signature in patients with glioma. Yue X; Zheng Y; Li L; Yang Z; Chen Z; Wang Y; Wang Z; Zhang D; Bian E; Zhao B Epigenomics; 2022 Sep; 14(18):1089-1104. PubMed ID: 36222052 [No Abstract] [Full Text] [Related]
6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
7. An immune-related lncRNA signature for patients with anaplastic gliomas. Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907 [TBL] [Abstract][Full Text] [Related]
8. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
9. Long Non-coding RNA Expression Profiling Identifies a Four-Long Non-coding RNA Prognostic Signature for Isocitrate Dehydrogenase Mutant Glioma. Chen Y; Guo Y; Chen H; Ma F Front Neurol; 2020; 11():573264. PubMed ID: 33329315 [No Abstract] [Full Text] [Related]
10. An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients. Sun Z; Jing C; Xiao C; Li T Aging (Albany NY); 2020 Aug; 12(15):15624-15637. PubMed ID: 32805727 [TBL] [Abstract][Full Text] [Related]
11. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas. Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476 [TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells. Zhang D; Zhou H; Liu J; Mao J Biomed Res Int; 2019; 2019():5437531. PubMed ID: 30949502 [TBL] [Abstract][Full Text] [Related]
13. The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1. Wang J; Gu J; You A; Li J; Zhang Y; Rao G; Ge X; Zhang K; Li J; Liu X; Wang Q; Lin T; Cheng L; Zhu M; Wu X; Wang D Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776110 [TBL] [Abstract][Full Text] [Related]
14. Genome-Wide Identification and Analysis of the Methylation of lncRNAs and Prognostic Implications in the Glioma. He Y; Wang L; Tang J; Han Z Front Oncol; 2020; 10():607047. PubMed ID: 33489915 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression. Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Yu H; Qi L J Exp Clin Cancer Res; 2019 Dec; 38(1):486. PubMed ID: 31823805 [TBL] [Abstract][Full Text] [Related]
16. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma. Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma. Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464 [TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer. Wang R; Li Y; Du P; Zhang X; Li X; Cheng G Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759 [TBL] [Abstract][Full Text] [Related]
19. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction. Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H Front Oncol; 2020; 10():590352. PubMed ID: 33392085 [TBL] [Abstract][Full Text] [Related]
20. Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer. Zhang G; Fan E; Zhong Q; Feng G; Shuai Y; Wu M; Chen Q; Gou X Hum Genomics; 2019 Aug; 13(1):36. PubMed ID: 31416476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]